CoreCap Advisors
IMCR icon

CoreCap Advisors’s Immunocore IMCR Stock Holding History

CoreCap Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$818 Hold
27
– – ﹤0.01% 2709
2026
Q2 		$857 Hold
27
– – ﹤0.01% 2733
2026
Q1 		$814 Hold
27
– – ﹤0.01% 2563
2025
Q4 		$937 Buy
+27
New +$953 ﹤0.01% 2613

Other funds holding IMCR

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return
Juncture Wealth Strategies
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CoreCap Advisors's IMCR Position: Q3 2026 in Review

CoreCap Advisors held its Immunocore (IMCR) position steady in Q3 2026 at 27 shares worth $818. The position accounts for ﹤0.01% of the portfolio, ranked #2709.

CoreCap Advisors first reported a position in IMCR in Q4 2025 and has held it in 4 quarters since. The position peaked at $937 in Q4 2025. 12 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

  • CoreCap Advisors held 27 shares of Immunocore worth $818 as of Q3 2026.
  • CoreCap Advisors left its Immunocore share count unchanged in Q3 2026.
  • Immunocore made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2709 holding.
  • CoreCap Advisors first reported a position in Immunocore in Q4 2025 and has held it in 4 quarters since.
  • CoreCap Advisors's Immunocore position peaked at $937 in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.